Conduit Pharmaceuticals I... (CDT)
NASDAQ: CDT
· Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.71
5.56%
After-hours: Aug 15, 2025, 07:24 PM EDT
Conduit Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
PE Ratio | 0.45 | -1.14 | -21.76 | -14.99 | -127.99 | -680.33 | 1.77K | 36.87 | -83.76 | -85.43 | -540.89 | -7.17K | -13.77K | -440.08 | -367.67K |
PEG Ratio | -0.00 | -0.00 | -0.11 | 0.15 | -2.81 | 0.00 | -90.01 | -0.36 | -24.19 | -0.16 | 7.44 | -0.75 | 142.36 | -0.01 | n/a |
PS Ratio | 0.16 | n/a | n/a | 0.59 | n/a | 18.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.09 | 0.02 | 0.16 | -42.48 | -504.56 | -3.14K | -27.57K | -270.93 | -37.68 | -45.65 | -659.42 | 207.93 | 49.37 | 4.10 | 312.48K |
P/FCF Ratio | 1.92 | -0.95 | -54.91 | -189.85 | -1.81K | -365.24 | -2.62K | -164.31 | -1.35K | -290.19 | -7.55K | -250.22K | -51.23K | -685.81 | n/a |
P/OCF Ratio | 1.33 | 3.16 | -54.91 | -193.75 | -1.82K | -4.12K | -2.62K | -164.31 | -1.35K | -290.19 | -7.55K | -250.22K | -51.23K | -685.81 | n/a |
OCF/S Ratio | 0.12 | n/a | n/a | -0.00 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.11 | 1.04 | 0.01 | -0.29 | -0.23 | -0.42 | -2.16 | -0.91 | -0.31 | -0.37 | -0.2 | n/a | n/a | n/a | 8.59 |
Quick Ratio | 1.35 | 1.29 | 79.43 | 0.12 | -130.74 | -187.13 | 3.18 | 2.27 | 0.06 | 0.00 | 0.16 | 3.63 | 9.57 | 18.55 | 0.54 |
Current Ratio | 1.99 | 1.93 | 111.37 | 0.12 | 0.56 | 1.59 | 3.18 | 2.27 | 0.06 | 0.00 | 0.16 | 3.63 | 9.57 | 18.55 | 0.54 |
Asset Turnover | 0.20 | n/a | n/a | 218.82 | n/a | 108.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -6.49 | -22.78 | -3.66 | -18.75 | -26.39 | -24.83 | -2.71 | -9.15 | -44.03 | -303 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.05 | n/a | n/a | 0.71 | 0.99 | 1.15 | -3.89 | -1.84 | 0.11 | 0.13 | 0.30 | -0.01 | n/a | n/a | -0.21 |
Return on Assets | 0.02 | n/a | -0.57 | -2.16 | -1.63 | -0.73 | 0.25 | 0.17 | -346.6 | -128.62 | -614.2 | -0.01 | n/a | n/a | -0.02 |
Return on Invested Capital | 0.03 | n/a | n/a | -7.51 | -1.99 | -0.96 | -0.14 | -0.05 | 0.29 | 0.41 | 0.53 | -0.01 | n/a | n/a | -0.02 |
Dividend Yield | 0.02 | 0.09 | 0.03 | 0.01 | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | 0.03 | -0.39 | -2.54 | -0.31 | n/a | -0.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.38 | n/a | n/a | 0.37 | n/a | 0.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | 0.09 | n/a | n/a | -0.01 | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | 0.10 | n/a | n/a | -0.01 | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | 0.12 | n/a | n/a | -0.01 | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.12 | n/a | n/a | -0.01 | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |